glp-1 drug updates Medicare is about to cover drugs for weight loss. Here's what to know Eli Lilly to seek approval

A second important observation is that tirzepatide has weaker activity relative to mGIP at the mGIPR

Emerging preclinical evidence suggests GLP-1 may influence neuronal survival, synaptic plasticity, and neuroinflammationprocesses that are disrupted in neurodegenerative conditions

In obese mice, Tirzepatide interventions have been shown to enhance -cell proliferation and function, reduce glucotoxicity, and extend life expectancy

However, for medications with a narrow therapeutic index , such as digoxin, closer monitoring is necessary

The proposed mechanism for the benefits of GLP-1 RAs in HS appears to involve both weight reduction and direct effects on the immune system [33]